Discover
ZLAB
Zai Lab Limited
19.15
2 x 14.08
2 x 24.38
bid
ask
+
0.15
0.79%
2 @ 04:00 PM
19.35 +0.20 (1.04%)
| Ytd | 8.56% | |
| 1y | -45.55% |
18.79
day range
19.61
15.96
52 week range
41.20
| Open | 19.05 | Prev Close | 19.00 | Low | 18.79 | High | 19.61 | Mkt Cap | 2.16B |
| Vol | 686.36K | Avg Vol | 890.39K | EPS | -1.70 | P/E | N/A | Forward P/E | -10.97 |
| Beta | 0.78 | Short Ratio | 7.54 | Inst. Own | 31.26% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 19.19 | 200-d Avg | 21.32 | 1yr Est | 33.30 |
| Income Statement | |||
| Total Revenue | 99.61M | ||
| Revenues (USD) | 99.61M | ||
| Cost of Revenue | 38.34M | ||
| Gross Profit | 61.28M | ||
| Operating Expenses | 130.50M | ||
| Research and Development Expense | 65.59M | ||
| Selling, General and Administrative Expense | 65.07M | ||
| Operating Income | -69.22M | ||
| Interest Expense | 1.64M | ||
| Income Tax Expense | 1.44M | ||
| Net Income | -51.02M | ||
| Net Income Common Stock | -51.02M | ||
| Net Income Common Stock (USD) | -51.02M | ||
| Consolidated Income | -51.02M | ||
| Earnings per Basic Share | -0.50 | ||
| Earnings per Basic Share (USD) | -0.50 | ||
| Earnings per Diluted Share | -0.50 | ||
| Earning Before Interest & Taxes (EBIT) | -47.94M | ||
| Earning Before Interest & Taxes (USD) | -47.94M | ||
| Weighted Average Shares | 1.11B | ||
| Weighted Average Shares Diluted | 1.11B | ||
| Balance Sheet | |||
| Cash and Equivalents | 751.32M | ||
| Cash and Equivalents (USD) | 751.32M | ||
| Investments | 19.05M | ||
| Investments Current | 17.93M | ||
| Investments Non-Current | 1.12M | ||
| Trade and Non-Trade Receivables | 54.07M | ||
| Current Assets | 944.73M | ||
| Property, Plant & Equipment Net | 64.65M | ||
| Total Assets | 1.10B | ||
| Debt Current | 219.80M | ||
| Total Debt | 231.91M | ||
| Current Liabilities | 392.98M | ||
| Debt Non-Current | 12.11M | ||
| Total Liabilities | 433.76M | ||
| Accumulated Retained Earnings (Deficit) | -2.68B | ||
| Accumulated Other Comprehensive Income | 15.11M | ||
| Shareholders Equity | 661.98M | ||
| Shareholders Equity (USD) | 661.98M | ||
| Assets Non-Current | 151.01M | ||
| Total Debt (USD) | 231.91M | ||
| Deferred Revenue | 28.63M | ||
| Goodwill and Intangible Assets | 78.63M | ||
| Inventory | 85.96M | ||
| Liabilities Non-Current | 40.77M | ||
| Trade and Non-Trade Payables | 126.17M | ||
| Tax Assets | 3.44M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.75M | ||
| Net Cash Flow from Financing | 5.57M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -28.26M | ||
| Capital Expenditure | -1.19M | ||
| Issuance (Purchase) of Equity Shares | 833.00K | ||
| Issuance (Repayment) of Debt Securities | 7.01M | ||
| Net Cash Flow from Investing | -22.29M | ||
| Net Cash Flow from Operations | -11.91M | ||
| Effect of Exchange Rate Changes on Cash | 371.00K | ||
| Share Based Compensation | 13.52M | ||